Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- Check5 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the page. This is a minor metadata update signaling a refreshed version rather than a substantive content change.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThis updates the displayed ClinicalTrials.gov page revision/version from v3.5.2 to v3.5.3, indicating a site version refresh rather than any change to the underlying study details.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 is now displayed and the prior revision (v3.4.1) was removed. This change does not affect study details, eligibility criteria, or outcomes on the page.SummaryDifference0.4%

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.